Latest filing published 30 Jan 2025 for Apellis Pharmaceuticals, Inc., €20k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adam J. Townsend: trading record in brief
Adam J. Townsend appears in our data through filings on Apellis Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 54 filings; the first trade dates from 10 February 2020 and the latest from 29 January 2025.
Sales make up the whole of the open-market record (24 sales, €12.5M). The rest of the record consists of 14 share grants and 15 option exercises. In 2025 alone, the filings show no purchases and 4 sales.
The record was last updated on 30 January 2025 with an open-market sale (€20k) in Apellis Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Adam J. Townsend
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 695 shares@ US$29.52360.2% of flowCommon StockSEC:0001127602-25-002387:0
- 3,323 shares@ US$30.42550.8% of flowCommon StockSEC:0001127602-25-001845:0
- 2,201 shares@ US$29.95820.5% of flowCommon StockSEC:0001127602-25-001629:0
- 2,685 shares@ US$28.70210.6% of flowCommon StockSEC:0001127602-25-001203:0
- 1,148 shares@ US$67.76690.6% of flowCommon StockSEC:0001127602-24-004734:0
- 906 shares@ US$64.13820.4% of flowCommon StockSEC:0001127602-24-002753:0
- 3,413 shares@ US$64.9961.7% of flowCommon StockSEC:0001127602-24-001960:0
- 23,748 shares0Common StockSEC:0001127602-24-001434:0
- 110,000 shares@ US$15.0912.5% of flowCommon StockSEC:0001127602-23-028964:0
- 67,557 shares@ US$60.501930.9% of flowCommon StockSEC:0001127602-23-028964:1
- 42,443 shares@ US$61.305219.7% of flowCommon StockSEC:0001127602-23-028964:2
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-014500:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-012593:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-009314:0
- 5,000 shares@ US$63.842.5% of flowCommon StockSEC:0001127602-23-009314:1
- 9,886 shares0Common StockSEC:0000899243-23-005779:0
- 782 shares@ US$51.210.3% of flowCommon StockSEC:0001127602-23-005169:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-003582:0
- 551 shares@ US$52.770.2% of flowCommon StockSEC:0001127602-23-002691:0
- 1,912 shares@ US$52.050.8% of flowCommon StockSEC:0001127602-23-002140:0
- 27,488 shares0Common StockSEC:0001127602-23-001501:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-001004:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0000899243-22-037834:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0000899243-22-035276:0
- 5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-22-023726:0
25 of 38 declarations
